Member Info for Thompi

Hope you don’t have a break from the board Bein.

You are an excellent poster and have been a stalwart supporter of AVCT. I think many of us at the moment share your frustration at the lack of comms.

Absolutely Mafuta, 12% is a considerable stake.

That was my thoughts too JohnHenry. I guess the next question is who has been buying them? Global Frontiers?

“I wish you all the very best for Thursday and a subsequent swift recovery. Make sure you report in 'shortly' :-)”

Touk, as D-Geeman says - all the very best.

I agree Gadgie that GMCC is 100% genuine. He adds a lot to the board and his posts are always measured and informative.

He had absolutely no reason to post a false email from AS. You could question some poster’s motives on here but definitely not GMCC’s.

A stark, rather depressing and probably correct post Bantham. What a mess.

Hi Bojo,

I agree with your 2024 timeline.

This is confirmed in the recent Trinity Delta research note. For example -

“The first LDTs could become available during 2024: (1) a prostate cancer LDT to assess the presence and severity of prostate cancer; and (2) an ovarian cancer pelvic mass triage LDT. “

And

“A prostate cancer LDT to assess the presence and severity of prostate cancer is currently in clinical trials, whilst the ovarian cancer pelvic mass triage LDT has completed clinical trials and a suitable third-party molecular analysis platform is being sought. Both of these LDTs could be available during 2024….”

Thanks Luke for taking the time to do your valuation. It is well reasoned, I thought it was a really interesting read.

Researcher, I guess a lot depends on what your cost average is regarding how you feel about SP targets between 44.5p - 56.6p. For me, having added at the 80p placing and with a high overall average it feels like a bit of a kick in the teeth.

If you bought in the twenties or thirties then you may be disposed to feel more charitable. Bit of a s**t show for long term investors. Andrew Holder replied to me in June last year after the disastrous AN interview - “Naturally, those that stay invested should see the highest returns”. I don’t think so Andrew.

hTTps://www.trinitydelta.org/research-notes/pursuing-a-multi-faceted-parsortix-commercial-opportunity/

Cheers Dflynch. I would recommend the Tele gram board. It’s a good board and is much easier for putting on links, screenshots etc.

LSE doesn’t like Tele gram links being put on, they have suspended me before. But if anyone is interested just Google Tele gram Angle and follow Tim’s twitter link.

Thanks Dflynch for your very detailed posts. Any chance please you could put them on the other boards. They are a set of very good posts.

I would suggest that people email the board if they are not happy with the low SP performance targets and put some pressure on them. Personally I think they should range from the 80p placing price up to a £1. AN & IG’s interests are not aligned with their shareholders if they benefit from anything under the 80p placement price that many investors forked for out at the time.

I have copied the remuneration members into my email, it’s about time they have some engagement with their shareholders.

I agree with some of what Gje306 says.

I have a huge amount of respect for Rah and his knowledge. But sometimes it can be a bit rampy - the £2 recent projection by SD (accompanied by the whale) or it will turn blue by the end of the day etc being recent examples.

AGL’s website is poor. No mention of the Solaris collaboration. The Ovarian page is out of date - it is still showing that the two clinical studies are ongoing even though they have been complete for months.

Come on AGL get your act together. I understand that a new website is in the pipeline, but this information is months out of date. It’s sloppy. The website is an important portal for potential investors and customers. AGL is not good at show casing its achievements.

Congratulations JS and team. Milestones & targets consistently hit.

No wonder he was brimming with enthusiasm in the presentation earlier in the week.

Sorry, I can’t edit my post, but the ?? at the end of it were LSE’s addition (they replaced the smiling face emoji that was on the original telegram post).

FFS, I tuned in this evening into our Telegram counterparts on the other board. Must admit this post from Andrew made me smile “ By the time this company rockets! I'll be pushing up daisies while a goth couple are shagging on top of my grave ??”

That’s exactly what I was writing Bazza, glad I saw your message before posting mine. JS talks unbelievably fast, it’s like someone turned up the speed dial, but as you say very enthusiastic and lots to look forward to.

I sadly agree with you FFS.

I am one of the one’s who have “been around long enough to have suffered huge losses in the valuation of their holdings.” (Does “one’s” have an apostrophe in it?)
I’m guessing that none of us (with the exception of Mulder) have made any money here?

I crystallised a big loss and then bought some more when I thought things had improved, which are also massively in the red. Not my best move. They are in my SIPP so I can’t offset them against anything. They have proved a very expensive mistake.

I hope we are not shafted and that it is us shareholders who gain from any value in the IP. But too much has gone in the past for me to very optimistic.

To be fair Gje, Ophidian has always stated that he is not trying to influence people. It is up to the individual if they react to Oph’s TA information.

I just don’t like his rudeness on the other board and the fact that he got you and Ben chucked off it. It’s pretty much bullying in disguise of knowledge.